Literature DB >> 8385346

Transcription initiation factor activity of vaccinia virus capping enzyme is independent of mRNA guanylylation.

N Harris1, R Rosales, B Moss.   

Abstract

Cytoplasmic extracts of vaccinia virus-infected HeLa cells blocked in DNA replication were capable of transcribing templates containing the minimal promoter sequences derived from three viral intermediate-stage genes (A1L, A2L, and G8R) but not promoters from early or late genes. One of three isolated components required for transcription copurified with the viral capping enzyme, a heterodimeric protein responsible for forming the 7-methyl-guanosine(5')triphospho(5')nucleoside [m7G(5')ppp(5')N-] structure at the 5' end of mRNAs, as had been reported using a template with another intermediate promoter [Vos, J. C., Sasker, M. & Stunnenberg, H. G. (1991) EMBO J. 10, 2553-2558]. Transcription factor activity was associated with partially, purified capping enzyme from infected cell extracts, homogeneous enzyme from purified virions, and recombinant viral enzyme from Escherichia coli. By transcribing truncated templates of different sizes, we determined that RNA chains of 35 nt were capped whereas those of 15 nt were not. Nevertheless, the capping enzyme was required for formation of short uncapped transcripts, indicating that capping and transcription initiation factor activities are independent functions.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8385346      PMCID: PMC46196          DOI: 10.1073/pnas.90.7.2860

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  Modification of the 5' end of mRNA. Association of RNA triphosphatase with the RNA guanylyltransferase-RNA (guanine-7-)methyltransferase complex from vaccinia virus.

Authors:  S Venkatesan; A Gershowitz; B Moss
Journal:  J Biol Chem       Date:  1980-02-10       Impact factor: 5.157

2.  Factors involved in specific transcription by human RNA polymerase II: analysis by a rapid and quantitative in vitro assay.

Authors:  M Sawadogo; R G Roeder
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

3.  Promoter-proximal pausing by RNA polymerase II in vitro: transcripts shorter than 20 nucleotides are not capped.

Authors:  J A Coppola; A S Field; D S Luse
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

4.  mRNA guanylyltransferase and mRNA (guanine-7-)-methyltransferase from vaccinia virions. Donor and acceptor substrate specificites.

Authors:  S A Martin; B Moss
Journal:  J Biol Chem       Date:  1976-12-10       Impact factor: 5.157

5.  Purification of mRNA guanylyltransferase and mRNA (guanine-7-) methyltransferase from vaccinia virions.

Authors:  S A Martin; E Paoletti; B Moss
Journal:  J Biol Chem       Date:  1975-12-25       Impact factor: 5.157

6.  Mechanism of RNA polymerase II--specific initiation of transcription in vitro: ATP requirement and uncapped runoff transcripts.

Authors:  D Bunick; R Zandomeni; S Ackerman; R Weinmann
Journal:  Cell       Date:  1982-07       Impact factor: 41.582

7.  Purification and characterization of a DNA-dependent RNA polymerase from vaccinia virions.

Authors:  B M Baroudy; B Moss
Journal:  J Biol Chem       Date:  1980-05-10       Impact factor: 5.157

8.  Identification of the DNA sequences encoding the large subunit of the mRNA-capping enzyme of vaccinia virus.

Authors:  J R Morgan; L K Cohen; B E Roberts
Journal:  J Virol       Date:  1984-10       Impact factor: 5.103

9.  Mechanism of mRNA capping by vaccinia virus guanylyltransferase: characterization of an enzyme--guanylate intermediate.

Authors:  S Shuman; J Hurwitz
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

10.  Vaccinia virus capping enzyme is a transcription initiation factor.

Authors:  J C Vos; M Sasker; H G Stunnenberg
Journal:  EMBO J       Date:  1991-09       Impact factor: 11.598

View more
  13 in total

1.  Regulation of viral intermediate gene expression by the vaccinia virus B1 protein kinase.

Authors:  G R Kovacs; N Vasilakis; B Moss
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

2.  Phenotypic analysis of a temperature sensitive mutant in the large subunit of the vaccinia virus mRNA capping enzyme.

Authors:  Amber N Shatzer; Sayuri E M Kato; Richard C Condit
Journal:  Virology       Date:  2008-03-04       Impact factor: 3.616

3.  The vaccinia virus H5R gene encodes late gene transcription factor 4: purification, cloning, and overexpression.

Authors:  G R Kovacs; B Moss
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

4.  The vaccinia virus A18R DNA helicase is a postreplicative negative transcription elongation factor.

Authors:  Y Xiang; D A Simpson; J Spiegel; A Zhou; R H Silverman; R C Condit
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

5.  A new vaccinia virus intermediate transcription factor.

Authors:  P Sanz; B Moss
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

6.  Mutational analysis of a predicted zinc-binding motif in the 26-kilodalton protein encoded by the vaccinia virus A2L gene: correlation of zinc binding with late transcriptional transactivation activity.

Authors:  J G Keck; F Feigenbaum; B Moss
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

7.  Overexpression, purification, and late transcription factor activity of the 17-kilodalton protein encoded by the vaccinia virus A1L gene.

Authors:  J G Keck; G R Kovacs; B Moss
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

8.  Modification of the cascade model for regulation of vaccinia virus gene expression: purification of a prereplicative, late-stage-specific transcription factor.

Authors:  G R Kovacs; R Rosales; J G Keck; B Moss
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

9.  A unique strategy for mRNA cap methylation used by vesicular stomatitis virus.

Authors:  Jianrong Li; Jennifer T Wang; Sean P J Whelan
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-18       Impact factor: 11.205

10.  A cellular factor is required for transcription of vaccinia viral intermediate-stage genes.

Authors:  R Rosales; G Sutter; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.